ABBOTT LABORATORIES — Director's Dealing 2007

Mar 29, 2007

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2007-03-27

Reporting Person: FREYMAN THOMAS C (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2007-03-27	Common shares without par value	M	41621	$45.4488	Acquired	309326	Direct
2007-03-27	Common shares without par value	F	36250	$57.24	Disposed	273076	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2007-03-27	Option (right to buy)	$45.4488	M	41621	Disposed	2011-02-08	common shares (41621)	Direct
2007-03-27	Option (right to buy)	$57.24	A	36250	Acquired	2011-02-08	common shares (36250)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	19351	Indirect
Common shares without par value	845	Indirect
Common shares without par value	845	Indirect
Common shares without par value	845	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of March 28, 2007.

F2: The reporting person disclaims beneficial ownership of all securities held by his daughter and sons.

F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

F4: 39,421 shares became exercisable on 2/09/03 and 2,200 shares became exercisable on 2/09/04.